Reply to Poddighe

por Stevenson, Louise, Huang, L-M, Berlaimont, Valérie, Folschweiller, Nicolas
Publicado 2017

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine

por Van Damme, Pierre, Leroux-Roels, Geert, Suryakiran, P., Folschweiller, Nicolas, Van Der Meeren, Olivier
Publicado 2017

97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View

por Tricou, Vianney, Biswal, Shibadas, Liu, Mengya, Patel, Sanjay S, Zent, Olaf, Rauscher, Martina, Perez, Gonzalo, Kandeil, Walid, Folschweiller, Nicolas
Publicado 2021

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue

por Sáez-Llorens, Xavier, Biswal, Shibadas, Borja-Tabora, Charissa, Fernando, LakKumar, Liu, Mengya, Wallace, Derek, Folschweiller, Nicolas, Reynales, Humberto, LeFevre, Inge
Publicado 2023

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

por Van Damme, Pierre, Dionne, Marc, Leroux‐Roels, Geert, Van Der Meeren, Olivier, Di Paolo, Emmanuel, Salaun, Bruno, Surya Kiran, Pemmaraju, Folschweiller, Nicolas
Publicado 2019

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age

por Schwarz, Tino F., Galaj, Andrzej, Spaczynski, Marek, Wysocki, Jacek, Kaufmann, Andreas M., Poncelet, Sylviane, Suryakiran, Pemmaraju V., Folschweiller, Nicolas, Thomas, Florence, Lin, Lan, Struyf, Frank
Publicado 2017

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

por Schwarz, Tino F., Huang, Li-Min, Valencia, Alejandra, Panzer, Falko, Chiu, Cheng-Hsun, Decreux, Annabelle, Poncelet, Sylviane, Karkada, Naveen, Folschweiller, Nicolas, Lin, Lan, Dubin, Gary, Struyf, Frank
Publicado 2019

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

por LeFevre, Inge, Bravo, Lulu, Folschweiller, Nicolas, Medina, Eduardo Lopez, Moreira, Edson Duarte, Nordio, Francesco, Sharma, Mayuri, Tharenos, Leslie M., Tricou, Vianney, Watanaveeradej, Veerachai, Winkle, Peter J., Biswal, Shibadas
Publicado 2023

Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study...

por Hu, Yuemei, Zhang, Xiang, He, Yilin, Ma, Zhilong, Xie, Yan, Lu, Xiangbin, Xu, Yabin, Zhang, Yanqiu, Jiang, Yunyu, Xiao, Hui, Struyf, Frank, Folschweiller, Nicolas, Jiang, Johny, Poncelet, Sylviane, Karkada, Naveen, Jastorff, Archana, Borys, Dorota
Publicado 2020

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

por Folschweiller, Nicolas, Behre, Ulrich, Dionne, Marc, Durando, Paolo, Esposito, Susanna, Ferguson, Linda, Ferguson, Murdo, Hillemanns, Peter, McNeil, Shelly A, Peters, Klaus, Ramjattan, Brian, Schwarz, Tino F, Supparatpinyo, Khuanchai, Suryakirian, Pemmaraju V, Janssens, Michel, Moris, Philippe, Decreux, Annabelle, Poncelet, Sylviane, Struyf, Frank
Publicado 2019

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in gi...

por Leung, Ting Fan, Liu, Anthony Pak-Yin, Lim, Fong Seng, Thollot, Franck, Oh, Helen May Lin, Lee, Bee Wah, Rombo, Lars, Tan, Ngiap Chuan, Rouzier, Roman, Friel, Damien, De Muynck, Benoit, De Simoni, Stéphanie, Suryakiran, Pemmaraju, Hezareh, Marjan, Folschweiller, Nicolas, Thomas, Florence, Struyf, Frank
Publicado 2015

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial

por Huang, Li-Min, Puthanakit, Thanyawee, Cheng-Hsun, Chiu, Ren-Bin, Tang, Schwarz, Tino, Pellegrino, Angelo, Esposito, Susanna, Frenette, Louise, McNeil, Shelly, Durando, Paolo, Rheault, Paul, Giaquinto, Carlo, Horn, Michael, Petry, Karl Ulrich, Peters, Klaus, Azhar, Toma, Hillemanns, Peter, De Simoni, Stephanie, Friel, Damien, Pemmaraju, Suryakiran, Hezareh, Marjan, Thomas, Florence, Descamps, Dominique, Folschweiller, Nicolas, Struyf, Frank
Publicado 2017

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized...

por Folschweiller, Nicolas, Teixeira, Julio, Joshi, Smita, Goldani, Luciano Z, Supparatpinyo, Khuanchai, Basu, Partha, Chotpitayasunondh, Tawee, Chetchotisakd, Ploenchan, Ruxrungtham, Kiat, Roteli-Martins, Cecilia, Grinsztejn, Beatriz, Quintana, Silvana Maria, Kumarasamy, Nagalingeswaran, Poongulali, Selvamuthu, Kulkarni, Vinay, Lin, Lan, Datta, Sanjoy K, Descamps, Dominique, Dodet, Monique, Dubin, Gary, Friel, Damien, Hezareh, Marjan, Karkada, Naveen, Meric Camilleri, Dorothee, Poncelet, Sylviane, Salaun, Bruno, Tavares-da-Silva, Fernanda, Thomas-Jooris, Florence, Struyf, Frank
Publicado 2020